60 related articles for article (PubMed ID: 38658677)
21. Persistent Cancer Cells: The Deadly Survivors.
Shen S; Vagner S; Robert C
Cell; 2020 Nov; 183(4):860-874. PubMed ID: 33186528
[TBL] [Abstract][Full Text] [Related]
22. Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening.
Li Z; Qian Y; Li W; Liu L; Yu L; Liu X; Wu G; Wang Y; Luo W; Fang F; Liu Y; Song F; Cai Z; Chen W; Huang W
iScience; 2020 Aug; 23(8):101411. PubMed ID: 32771979
[TBL] [Abstract][Full Text] [Related]
23. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
Kurppa KJ; Liu Y; To C; Zhang T; Fan M; Vajdi A; Knelson EH; Xie Y; Lim K; Cejas P; Portell A; Lizotte PH; Ficarro SB; Li S; Chen T; Haikala HM; Wang H; Bahcall M; Gao Y; Shalhout S; Boettcher S; Shin BH; Thai T; Wilkens MK; Tillgren ML; Mushajiang M; Xu M; Choi J; Bertram AA; Ebert BL; Beroukhim R; Bandopadhayay P; Awad MM; Gokhale PC; Kirschmeier PT; Marto JA; Camargo FD; Haq R; Paweletz CP; Wong KK; Barbie DA; Long HW; Gray NS; Jänne PA
Cancer Cell; 2020 Jan; 37(1):104-122.e12. PubMed ID: 31935369
[TBL] [Abstract][Full Text] [Related]
24. Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in
Schoenfeld AJ; Chan JM; Kubota D; Sato H; Rizvi H; Daneshbod Y; Chang JC; Paik PK; Offin M; Arcila ME; Davare MA; Shinde U; Pe'er D; Rekhtman N; Kris MG; Somwar R; Riely GJ; Ladanyi M; Yu HA
Clin Cancer Res; 2020 Jun; 26(11):2654-2663. PubMed ID: 31911548
[TBL] [Abstract][Full Text] [Related]
25. A view on drug resistance in cancer.
Vasan N; Baselga J; Hyman DM
Nature; 2019 Nov; 575(7782):299-309. PubMed ID: 31723286
[TBL] [Abstract][Full Text] [Related]
26. Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.
Mehlman C; Cadranel J; Rousseau-Bussac G; Lacave R; Pujals A; Girard N; Callens C; Gounant V; Théou-Anton N; Friard S; Trédaniel J; Blons H; Dujon C; Duchemann B; Schischmanoff PO; Chinet T; Giroux Leprieur E
Lung Cancer; 2019 Nov; 137():149-156. PubMed ID: 31600593
[TBL] [Abstract][Full Text] [Related]
27. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer.
Leonetti A; Sharma S; Minari R; Perego P; Giovannetti E; Tiseo M
Br J Cancer; 2019 Oct; 121(9):725-737. PubMed ID: 31564718
[TBL] [Abstract][Full Text] [Related]
28. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer.
Raoof S; Mulford IJ; Frisco-Cabanos H; Nangia V; Timonina D; Labrot E; Hafeez N; Bilton SJ; Drier Y; Ji F; Greenberg M; Williams A; Kattermann K; Damon L; Sovath S; Rakiec DP; Korn JM; Ruddy DA; Benes CH; Hammerman PS; Piotrowska Z; Sequist LV; Niederst MJ; Barretina J; Engelman JA; Hata AN
Oncogene; 2019 Sep; 38(37):6399-6413. PubMed ID: 31324888
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the Hippo Pathway Transcription Factor TEAD.
Lin KC; Park HW; Guan KL
Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
[TBL] [Abstract][Full Text] [Related]
30. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
[TBL] [Abstract][Full Text] [Related]
31. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
[TBL] [Abstract][Full Text] [Related]
32. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex.
Konermann S; Brigham MD; Trevino AE; Joung J; Abudayyeh OO; Barcena C; Hsu PD; Habib N; Gootenberg JS; Nishimasu H; Nureki O; Zhang F
Nature; 2015 Jan; 517(7536):583-8. PubMed ID: 25494202
[TBL] [Abstract][Full Text] [Related]
33. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.
Li W; Xu H; Xiao T; Cong L; Love MI; Zhang F; Irizarry RA; Liu JS; Brown M; Liu XS
Genome Biol; 2014; 15(12):554. PubMed ID: 25476604
[TBL] [Abstract][Full Text] [Related]
34. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.
Varelas X
Development; 2014 Apr; 141(8):1614-26. PubMed ID: 24715453
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of epithelial-mesenchymal transition.
Lamouille S; Xu J; Derynck R
Nat Rev Mol Cell Biol; 2014 Mar; 15(3):178-96. PubMed ID: 24556840
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library.
Koike-Yusa H; Li Y; Tan EP; Velasco-Herrera Mdel C; Yusa K
Nat Biotechnol; 2014 Mar; 32(3):267-73. PubMed ID: 24535568
[TBL] [Abstract][Full Text] [Related]
37. Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Shi H; Hugo W; Kong X; Hong A; Koya RC; Moriceau G; Chodon T; Guo R; Johnson DB; Dahlman KB; Kelley MC; Kefford RF; Chmielowski B; Glaspy JA; Sosman JA; van Baren N; Long GV; Ribas A; Lo RS
Cancer Discov; 2014 Jan; 4(1):80-93. PubMed ID: 24265155
[TBL] [Abstract][Full Text] [Related]
38. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
Straussman R; Morikawa T; Shee K; Barzily-Rokni M; Qian ZR; Du J; Davis A; Mongare MM; Gould J; Frederick DT; Cooper ZA; Chapman PB; Solit DB; Ribas A; Lo RS; Flaherty KT; Ogino S; Wargo JA; Golub TR
Nature; 2012 Jul; 487(7408):500-4. PubMed ID: 22763439
[TBL] [Abstract][Full Text] [Related]
39. Role of YAP/TAZ in mechanotransduction.
Dupont S; Morsut L; Aragona M; Enzo E; Giulitti S; Cordenonsi M; Zanconato F; Le Digabel J; Forcato M; Bicciato S; Elvassore N; Piccolo S
Nature; 2011 Jun; 474(7350):179-83. PubMed ID: 21654799
[TBL] [Abstract][Full Text] [Related]
40. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).
Zhao B; Li L; Tumaneng K; Wang CY; Guan KL
Genes Dev; 2010 Jan; 24(1):72-85. PubMed ID: 20048001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
